GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $856,000 | -78.3% | 26,780 | -76.5% | 0.04% | -76.7% |
Q1 2022 | $3,952,000 | +121.0% | 114,092 | +237.7% | 0.18% | +78.2% |
Q1 2019 | $1,788,000 | +28.7% | 33,789 | -0.2% | 0.10% | -5.6% |
Q4 2018 | $1,389,000 | +64.4% | 33,844 | +93.4% | 0.11% | +197.2% |
Q1 2018 | $845,000 | -47.3% | 17,500 | -70.1% | 0.04% | -58.6% |
Q2 2017 | $1,603,000 | +55.6% | 58,600 | -5.6% | 0.09% | +61.1% |
Q2 2016 | $1,030,000 | – | 62,100 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
Grace Capital | 98,939 | $13,970,000 | 5.34% |
GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |